JUN and neoplasm: Consistent with our conclusion that this is due to the abrogated activation of JNK in these xenograft tumors, the tumor-derived tissue samples showed a reduction in the expression as well as activation of JNK (Figures 5 and 6) along with a decrease in the levels of activated phosphorylated c-Jun (Figure 6B).